Stereotaxis Inc (STXS)
2.04
-0.05
(-2.39%)
USD |
NYAM |
Nov 15, 16:00
2.03
-0.01
(-0.49%)
After-Hours: 20:00
Stereotaxis Research and Development Expense (TTM): 9.182M for Sept. 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 9.182M |
| June 30, 2024 | 9.396M |
| March 31, 2024 | 9.77M |
| December 31, 2023 | 10.27M |
| September 30, 2023 | 10.46M |
| June 30, 2023 | 10.61M |
| March 31, 2023 | 10.86M |
| December 31, 2022 | 10.56M |
| September 30, 2022 | 10.77M |
| June 30, 2022 | 10.46M |
| March 31, 2022 | 10.28M |
| December 31, 2021 | 10.20M |
| September 30, 2021 | 9.682M |
| June 30, 2021 | 9.135M |
| March 31, 2021 | 8.395M |
| December 31, 2020 | 8.137M |
| September 30, 2020 | 7.655M |
| June 30, 2020 | 7.453M |
| March 31, 2020 | 8.171M |
| December 31, 2019 | 9.021M |
| September 30, 2019 | 9.629M |
| June 30, 2019 | 9.879M |
| March 31, 2019 | 9.216M |
| December 31, 2018 | 8.219M |
| September 30, 2018 | 7.723M |
| Date | Value |
|---|---|
| June 30, 2018 | 7.342M |
| March 31, 2018 | 7.066M |
| December 31, 2017 | 6.704M |
| September 30, 2017 | 6.275M |
| June 30, 2017 | 5.950M |
| March 31, 2017 | 5.615M |
| December 31, 2016 | 5.488M |
| September 30, 2016 | 6.043M |
| June 30, 2016 | 6.242M |
| March 31, 2016 | 6.240M |
| December 31, 2015 | 6.253M |
| September 30, 2015 | 5.528M |
| June 30, 2015 | 5.248M |
| March 31, 2015 | 5.141M |
| December 31, 2014 | 5.158M |
| September 30, 2014 | 5.389M |
| June 30, 2014 | 5.475M |
| March 31, 2014 | 5.646M |
| December 31, 2013 | 5.672M |
| September 30, 2013 | 5.793M |
| June 30, 2013 | 6.397M |
| March 31, 2013 | 7.109M |
| December 31, 2012 | 8.405M |
| September 30, 2012 | 9.578M |
| June 30, 2012 | 11.20M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
7.453M
Minimum
Jun 2020
10.86M
Maximum
Mar 2023
9.523M
Average
9.726M
Median
Research and Development Expense (TTM) Benchmarks
| Cutera Inc | 18.38M |
| IRIDEX Corp | 6.272M |
| Electromed Inc | 0.656M |
| Axogen Inc | 29.23M |
| Myomo Inc | 4.090M |